Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07727785) titled 'A Study in Healthy People to Compare Two Tablet Formulations of Pramipexole' on July 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Boehringer Ingelheim

Condition: Healthy

Intervention: Drug: Sifrol(R)

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: August 5, 2026

Target Sample Size: 24

Countries of Recruitment: Germany

To know more, visit https://clinicaltrials.gov/study/NCT07727785

Disclaimer: Curated by HT Syndication....